Join
Live feed
·
FDARegulatoryvia Quantisnow
ClearPoint Neuro Inc. logo
PTC Therapeutics Inc. logo

November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

ByQuantisnow·Wall Street's wire, on your screen.
CLPT· ClearPoint Neuro Inc.PTCT· PTC Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLPT (ClearPoint Neuro Inc.), PTCT (PTC Therapeutics Inc.) and more on Quantisnow.